mrc-ide/EPIONCHO.IBM: Incorporation of morbidity, correlated compliance and anti-Ov16 seroprevalence

Changes since v1.0.0 : • morbidity module (onchocerciasis skin and ocular disease) • correlated compliance scheme for systematic non-compliance in MDA • Ov16 dynamics for serology • Updated documentation (new vignettes) This updates v1.1.0 by: • cleaning files in main directory • fully updated vignettes for morbidity This supports the following paper: Onchocerciasis-associated skin and ocular disease and the impact of ivermectin treatment: a modelling study Matthew A. Dixon1†*, Aditya Ramani1,2†, Martin Walker1,2, Jacob N. Stapley1, Michele E. Murdoch3, Ian E. Murdoch4, Gladys A. Ozoh5, Jonathan F. Mosser6,7, Maria-Gloria Basáñez1* 1MRC Centre for Global Infectious Disease Analysis and London Centre for Neglected Tropical Disease Research, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, 90 Wood Lane, London, W12 0BZ, UK 2Department of Pathobiology and Population Sciences, Royal Veterinary College, Hawkshead Lane, Hatfield, Hertfordshire, AL9 7TA, UK 3Department of Dermatology, West Herts Teaching Hospitals NHS Trust, Watford, Herts., UK 4International Centre for Eye Health, Institute of Ophthalmology, London, UK 5Dermatology Division, University of Nigeria Teaching Hospital, Ituku Ozala Enugu State, Nigeria 6Institute for Health Metrics and Evaluation, Hans Rosling Center for Population Health, 3980 15th Ave NE, Seattle WA 98195, USA 7Department of Global Health, School of Public Health, and Seattle Children’s Hospital, University of Washington, Seattle WA, USA †Contributed equally Communications Medicine